Remedee Labs raised €12.2M series A from Generali France, CVC, Habert Dassault Finance, Bpifrance
07 December 2022
07 December 2022
Total investments received (USD): 12.83M
Round value (USD): 12.83M
Company: Remedee Labs
Related deals
May health in a €10M series B extension led by Nexpring Health, joined by existing shareholders Sofinnova Partners, Bpifrance, and Trill Impact.
Investments
02 March 2026
Lifeaz in a €13M series A round with Mutuelles Impact, BNP Paribas, GO CAPITAL, and Mirova, an affiliate of Natixis
Investments
01 February 2026
4Moving Biotech raised a €12 million financing with 4P-Pharma, Fondation Arthritis, SATT Lutech, Business Angels, Family Offices in France
Investments
17 January 2026
ErVimmune raised €17 million Series A financing with Seventure and SPRIM Global
Investments
06 January 2026
NcodiN raised €16 million in a seed funding round led by MIG Capital joined by Maverick Silicon, PhotonVentures, Verve Ventures, Elaia, Earlybird, and OVNI.
Investments
04 November 2025
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Portugal
Spain
United Kingdom